Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Images in clinical medicine. Gynecomastia induced by prostate-cancer treatment.

Michalopoulos NV, Keshtgar MR.

N Engl J Med. 2012 Oct 11;367(15):1449. doi: 10.1056/NEJMicm1209166. No abstract available.

2.

[Gynecomastia as a complication of hormonotherapy for prostate cancer: effect of prophylactic breast irradiation].

Abdah-Bortnyak R, Bernstein Z, Ramon N, Zalman D, Shnaider J, Kuten A.

Harefuah. 2007 Feb;146(2):126-8, 164-5. Review. Hebrew.

PMID:
17352282
3.

[Management of gynecomastia induced by bicalutamide].

Haddad E.

Ann Urol (Paris). 2006 Dec;40 Suppl 2:S49-52. Review. French.

PMID:
17361921
5.

The role of tamoxifen in reducing bicalutamide-induced gynaecomastia and breast pain.

Nuttall MC, Harris JP, Dawkins GP.

BJU Int. 2007 Feb;99(2):243-4. No abstract available.

6.

Depression related to (neo)adjuvant hormonal therapy for prostate cancer.

van Tol-Geerdink JJ, Leer JW, van Lin EN, Schimmel EC, Stalmeier PF.

Radiother Oncol. 2011 Feb;98(2):203-6. doi: 10.1016/j.radonc.2010.12.006. Epub 2011 Jan 20.

PMID:
21256610
7.

Gynecomastia and breast pain induced by adjuvant therapy with bicalutamide after radical prostatectomy in patients with prostate cancer: the role of tamoxifen and radiotherapy.

Di Lorenzo G, Perdonà S, De Placido S, D'Armiento M, Gallo A, Damiano R, Pingitore D, Gallo L, De Sio M, Autorino R.

J Urol. 2005 Dec;174(6):2197-203.

PMID:
16280763
8.

A case of male breast cancer in association with bicalutamide-induced gynaecomastia.

Chianakwalam CI, McCahy P, Griffiths NJ.

Breast. 2005 Apr;14(2):163-4. No abstract available.

PMID:
15767188
9.

Treatment of bicalutamide-induced breast events.

Sieber PR.

Expert Rev Anticancer Ther. 2007 Dec;7(12):1773-9. Review.

PMID:
18062751
10.

Bicalutamide-induced gynaecomastia: do we have the answer?

Di Lorenzo G, Autorino R.

Eur Urol. 2007 Jul;52(1):5-8. Epub 2007 Jan 22. No abstract available.

PMID:
17258386
11.

Photosensitive drug eruption induced by bicalutamide within the UVB action spectrum.

Sasada K, Sakabe J, Tamura A, Kasuya A, Shimauchi T, Ito T, Hirakawa S, Tokura Y.

Eur J Dermatol. 2012 May-Jun;22(3):402-3. doi: 10.1684/ejd.2012.1719. No abstract available.

PMID:
22503957
12.

Radiotherapeutic prophylaxis of gynecomastia.

Thönnessen D, Wenz F.

J Clin Oncol. 2005 Aug 20;23(24):5845; author reply 5846-7. No abstract available.

PMID:
16110041
13.

A randomized trial comparing tamoxifen therapy vs. tamoxifen prophylaxis in bicalutamide-induced gynecomastia.

Serretta V, Altieri V, Morgia G, Nicolosi F, De Grande G, Mazza R, Melloni D, Allegro R, Ferraù F, Gebbia V.

Clin Genitourin Cancer. 2012 Sep;10(3):174-9. doi: 10.1016/j.clgc.2012.03.002. Epub 2012 Apr 12.

PMID:
22502790
14.

Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response study.

Fradet Y, Egerdie B, Andersen M, Tammela TL, Nachabe M, Armstrong J, Morris T, Navani S.

Eur Urol. 2007 Jul;52(1):106-14. Epub 2007 Jan 16.

PMID:
17270340
15.

Treatment of bicalutamide-induced gynecomastia with breast-reduction surgery in prostate cancer.

Nakabayashi M, Bartlett RA, Oh WK.

J Clin Oncol. 2006 Jun 20;24(18):2958-9. No abstract available.

PMID:
16782932
16.

Bicalutamide.

[No authors listed]

Prescrire Int. 2007 Apr;16(88):67.

PMID:
17458049
17.

Profound bicalutamide withdrawal syndrome in a hormone-refractory T4N1 prostate cancer permitting both salvage radiotherapy and cessation of hormonal therapy.

Takeshita H, Kawakami S, Fukui I.

Int J Urol. 2009 Mar;16(3):337-8. doi: 10.1111/j.1442-2042.2008.02189.x. No abstract available.

18.

Prostate cancer tissue is masked by bicalutamide: a case report.

Ellinger J, Bastian PJ, Biermann K, Schmidt ME, Textor J, Bollmann D, Zhou H, Müller SC.

Eur J Med Res. 2007 May 29;12(5):212-5.

PMID:
17513193
19.

Drug-related hepatotoxicity and hepatic failure following combined androgen blockade.

Castro Beza I, Sánchez Ruiz J, Peracaula Espino FJ, Villanego Beltrán MI.

Clin Transl Oncol. 2008 Sep;10(9):591-2.

PMID:
18796378
20.

Is prophylactic breast radiotherapy necessary in all patients with prostate cancer and gynecomastia and/or breast pain?

Ozen H, Akyol F, Toktas G, Eskicorapci S, Unluer E, Kuyumcuoglu U, Abay E, Cureklibatur I, Sengoz M, Yalcin V, Akpinar H, Zorlu F, Sengor F, Karaman I.

J Urol. 2010 Aug;184(2):519-24. doi: 10.1016/j.juro.2010.03.137. Epub 2010 Jun 17.

PMID:
20620411

Supplemental Content

Support Center